Biotech entity

ICON plc

Company ICLR

All 1 tracked stories fall under one category: pharma. ICON plc is most often covered alongside Advarra, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window.

Last mentioned: Mar 24, 2026

Entity pulse

Recent coverage · ICON plc

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about ICON plc

All 1 tracked stories fall under one category: pharma. ICON plc is most often covered alongside Advarra, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window. The 6 average consequence score is above the beat benchmark of 5.9 in the same window. We currently track 1 Biotech story that mention ICON plc, all published on March 24, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering ICON plc. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Performance Review

    Analysis of startup timeline improvements and data quality metrics.

  2. Initial Implementation

    Rollout of the model across select ICON-managed clinical trials.

  3. Model Launch

    ICON and Advarra officially introduce the Research-Ready, Connected Site Network Model.

  4. Network Expansion

    Onboarding of additional sites into the 'Research-Ready' ecosystem.

Stories mentioning ICON plc 1

Pharma Positive

ICON and Advarra Launch Connected Site Model to Accelerate Clinical Trials

ICON plc and Advarra have introduced a new 'Research-Ready, Connected Site Network Model' designed to bridge the gap between clinical research sites and sponsors. The partnership aims to reduce trial startup timelines and administrative burdens through integrated technology and standardized workflows.

2 sources

ICON plc is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.